Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Finland
  4. Nasdaq Helsinki
  5. Nanoform Finland Oyj
  6. News
  7. Summary
    NANOFH   FI4000330972

NANOFORM FINLAND OYJ

(NANOFH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Nanoform Finland Oyj : , Herantis Pharma Complete Parkinson's Drug Combo Proof Of Concept

09/09/2021 | 04:15am EDT


ę MT Newswires 2021
All news about NANOFORM FINLAND OYJ
08:44aNANOFORM FINLAND OYJ : trailblazing progress earns recognition from prestigious industry a..
PU
10/18NANOFORM FINLAND OYJ : convenes EGM to elect Jeanne Thoma as board member
AQ
10/18NANOFORM FINLAND OYJ : Notice to the Extraordinary General Meeting of NANOFORM FINLAND PLC
AQ
09/29NANOFORM FINLAND OYJ : receives funding to solve challenges for global health
AQ
09/24NANOFORM FINLAND OYJ : Plc – Manager's transactions – Gonçalo Andrade
PU
09/24NANOFORM FINLAND PLC : - Manager's transactions - Gonçalo Andrade
AQ
09/23NANOFORM FINLAND OYJ : shortlisted for the European Small and Mid-Cap Awards 2021
AQ
09/09NANOFORM FINLAND OYJ : Herantis Pharma Complete Parkinson's Drug Combo Proof Of Concept
MT
09/09NANOFORM FINLAND OYJ : technology delivers successful results for Herantis CDNF drug candi..
AQ
09/09HERANTIS PHARMA OYJ : Announces Successful rhCDNF Results With Nanoform Technology
AQ
More news
Financials
Sales 2021 2,85 M 3,30 M 3,30 M
Net income 2021 -19,3 M -22,4 M -22,4 M
Net cash 2021 72,2 M 83,7 M 83,7 M
P/E ratio 2021 -28,1x
Yield 2021 -
Capitalization 551 M 641 M 639 M
EV / Sales 2021 168x
EV / Sales 2022 54,9x
Nbr of Employees 106
Free-Float 71,2%
Chart NANOFORM FINLAND OYJ
Duration : Period :
Nanoform Finland Oyj Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NANOFORM FINLAND OYJ
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 7,60 €
Average target price 9,15 €
Spread / Average Target 20,4%
EPS Revisions
Managers and Directors
Edward HŠggstr÷m Chief Executive Officer
Albert Hńggstr÷m Chief Financial Officer & Director
Miguel Maria de Oliveira Barreiros Calado Chairman
Niklas Sandler Chief Technology Officer
Gonšalo Nuno N. da Silva Rebelo de Andrade Chief Business Operations
Sector and Competitors
1st jan.Capi. (M$)
NANOFORM FINLAND OYJ7.34%641
JOHNSON & JOHNSON4.03%430 990
ROCHE HOLDING AG15.15%337 974
NOVO NORDISK A/S58.77%242 392
PFIZER, INC.17.25%241 985
ELI LILLY AND COMPANY44.37%220 979